Latest news
Hopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy - citybizcitybiz · Mon, 10 Aug 2026 12:56:43 GMTHopstem Announces the first Closing of Series C Financing to Accelerate the Development of iPSC-Derived Forebrain Neural Cell Therapy - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 10:17:42 GMTEngineered Human Interneuron Transplants Repair Respiratory Circuits in Injured Rats - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Thu, 06 Aug 2026 20:41:07 GMTThe Pipeline for iPSC-Derived Cell Therapeutics in 2026 - bioinformant.combioinformant.com · Sun, 02 Aug 2026 07:00:00 GMT